Self-Inspection Program - GMP SOP
A self-inspection program, which can be applied to all GMP-regulated pharmaceutical areas (drug products, active pharmaceutical ingredients and devices), should encompass all current good pharmaceutical manufacturing practices (cGMP). It is an effective and powerful tool for ensuring compliance with relevant GMP and regulatory requirements.
The self-inspection program should be implemented to identify non-conformance and to resolve this by defining and monitoring appropriate corrective measures. Non-conformance should be rated according to how critical it is and resolved through corrective and preventive action (CAPA) to ensure the continuous improvement of all quality-related operations and systems.
This 12-page Standard Operating Procedure (SOP) also defines the procedures and responsibilities for self-inspection planning, implementation and follow-up to ensure compliance with regulatory, cGMP and internal quality procedures. Three templates are included: a self-inspection schedule for the year, a self-inspection summary report and a self-inspection issue report.
Table of Content
1. Regulatory Basis, Reference Documents
4. Responsibilities and Accountabilities
4.1 Site Head
4.2 Quality Head
4.3 Lead Auditor
4.4 Audit Team
4.5 Auditee/Area Leader
5.2 Self-inspection preparation
5.3 Conduct Self-inspection
5.4 Self-Inspection Report
5.5 Self-Inspection follow-up
5.6 Issue Categorization
APPENDIX 1: SELF-INSPECTION SCHEDULE
APPENDIX 2: SELF-INSPECTION REPORT Part 1
APPENDIX 3: SELF-INSPECTION REPORT Part 2
|SKU||Self-Inspection Program - GMP SOP|
What you will get:
Delivery item: Word Document
You will be able to enter your data into the Word document.
Please note: We do not deliver hard copies.